Published in:
01-02-2020 | Conservative Therapy | Arthroscopy and Sports Medicine
No superiority of dextrose injections over placebo injections for Osgood–Schlatter disease: a prospective randomized double-blind study
Authors:
Junsuke Nakase, Takeshi Oshima, Yasushi Takata, Kengo Shimozaki, Kazuki Asai, Hiroyuki Tsuchiya
Published in:
Archives of Orthopaedic and Trauma Surgery
|
Issue 2/2020
Login to get access
Abstract
Purpose
Osgood–Schlatter disease (OSD) is a traction apophysitis of the tibial tuberosity. Patellar tendinopathy and deep infrapatellar bursitis have recently been shown to contribute to pain in patients with OSD. We compared the effects of dextrose injection and saline injection.
Methods
We performed a clinical trial from April 2012 to January 2016 and included 49 knees from 37 boys and 1 girl (mean age, 12.3 ± 1.1 years) for whom conventional conservative therapy for > 1 month was ineffective. They were randomly assigned to receive double-blind injections of 1% lidocaine (1 mL) with 20% dextrose (1 mL; dextrose group) or 1% lidocaine (1 mL) with saline (1 mL; saline group). Injections were administered monthly for 3 months by a single investigator. The Victorian Institute of Sport Assessment (VISA) score was used to evaluate anterior knee pain.
Results
Overall, 43 knees were included; 6 knees were lost to follow-up. The mean pre-injection VISA scores in the dextrose and saline groups were 58.7 ± 18.3 and 63.4 ± 16.4, respectively. No significant differences were found between the two groups at any time point. The mean VISA score before injections significantly increased at the 1-month follow-up in both groups (P < .01). The injection had no adverse effects.
Conclusions
We were not able to show the efficacy of dextrose injections compared to that of saline.
Level of evidence
Randomized controlled trial. Level I.